Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-ethylmaleimide-sensitive factor attachment protein, gamma pseudogene 2" (NAPGP2) refers to a putative, non-functional segment of DNA related to the N-ethylmaleimide-sensitive factor attachment protein family. The "pseudogene" annotation indicates that this locus does not encode an active protein and has no known biological function, therapeutic relevance, or disease association. No structured protein, pharmacology, or disease information is available for NAPGP2, distinguishing it from bona fide targets such as the functional N-ethylmaleimide-sensitive factor (NSF) or Soluble NSF Attachment Proteins (SNAPs), which are well-characterized in membrane fusion and trafficking[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-ethylmaleimide-sensitive factor attachment protein, gamma pseudogene 2 (NAPGP2).